(R)-3-Boc-4-isopropyl-2,2-dioxo-[1,2,3]oxathiazolidine, 97%, 250mg

(3S,6R)-1-(6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)pyrimidin-4-yl)-N-cyclohexyl-6-methylpiperidine-3-carboxamide, 98%, 25mg

1-(Benzenesulfonyl)-6-chloro-2-iodo-1H-pyrrolo[3,2-c]pyridine, 95+%, 1g

1-Nitroanthraquinone>98.0%(GC)25g

n-Hexane, min.99%, pour la synthèse, 100 ml, emballage en verre

2,5-Dichloropyridin-4-amine, 95.0%, 5g

2-trans-Dodecenoyl-Co A>86.0%(HPLC)5mg

Pipettes jaugées 1 marque classe AS, 20 ml, 6 pièces

2-Chloro-5-(pentafluoroethyl)thiophene, 250mg

5-methyl-6-nitro-1,3-benzodioxole, 95.0%, 5g

n-(2-Aminoethyl)-2,2-dimethylpropanamide hydrochloride, 95%, 250mg

Pipette microlitre monocanal Transferpette® S variable, 500 à 5000 µl, D-5000, 1 pièce

Ethyl 2-(1-methylguanidino)acetate hydrochloride, 95.0%, 5g